2004
Budesonide versus prednisolone for the treatment of active Crohn's disease in children: A randomized, double-blind, controlled, multicentre trial
Publication
Publication
European Journal of Gastroenterology and Hepatology , Volume 16 - Issue 1 p. 47- 54
Objectives: Budesonide is a corticosteroid with low systemic bioavailability because of its high first-pass metabolism in the liver. In this paediatric, randomized, double-blind, double-dummy, controlled, multicentre trial, the safety and efficacy of budesonide versus prednisolone were evaluated in children with active Crohn's disease. Methods: Forty-eight children, aged 6-16 years, with active Crohn's disease (Crohn's Disease Activity Index > 200) involving ileum and/or ascending colon were randomized to receive budesonide (9 mg/day for 8 weeks, 6 mg/day for 4 weeks) or prednisolone (1 mg/kg/day for 4 weeks, tapering for 8 weeks). Results: The groups were comparable for age, sex, pubertal stage, disease activity and disease duration. Mean morning plasma cortisol concentration was significantly higher in the budesonide group (200 nmol/l) than in the prednisolone group (98 nmol/l) after 8 weeks, reflecting less adrenal suppression by budesonide (difference -102 nmol/l; 95% CI -226, -52; P = 0.0028). Glucocorticosteroid side effects such as moon face and acne occurred significantly less frequently in the budesonide group. Remission (Crohn's Disease Activity Index ≤150) was seen at 8 weeks in 12/22 (55%) patients treated with budesonide and in 17/24 (71%) patients receiving prednisolone (difference -16%; 95% CI -45, 13; P = 0.25). Conclusions: Significantly fewer side effects and less adrenal suppression were observed in the children receiving budesonide. Remission rates were not significantly different in the two groups. However, there was a trend for prednisolone to be more effective for inducing remission. Eur J Gastroenterol Hepatol 16:47-54
Additional Metadata | |
---|---|
, , , , | |
doi.org/10.1097/00042737-200401000-00008, hdl.handle.net/1765/71215 | |
European Journal of Gastroenterology and Hepatology | |
Organisation | Department of Pediatrics |
Escher, J. (2004). Budesonide versus prednisolone for the treatment of active Crohn's disease in children: A randomized, double-blind, controlled, multicentre trial. European Journal of Gastroenterology and Hepatology, 16(1), 47–54. doi:10.1097/00042737-200401000-00008 |